Glaucoma is a chronic eye disorder characterized by elevated intraocular pressure, which can lead to optic nerve damage and irreversible vision loss if untreated. Acetazolamide, a carbonic anhydrase inhibitor, effectively reduces aqueous humor production, but conventional ocular formulations are limited by poor bioavailability, rapid precorneal clearance, and the need for frequent dosing. To address these challenges, an acetazolamide-loaded in-situ cubogel was developed to provide sustained, targeted, and patient-friendly ocular delivery.Cubosomes were prepared using the top-down technique and optimized through a Box-Behnken Design. The optimized cubosome formulation contained 6.2% w/v Glyceryl monooleate, 0.35% w/v Pluronic F127 and 6.8 minutes sonication time, resulting in particle size of 256.7 nm, PDI of 0.473, zetapotential of 7.53 mV and entrapment efficiency of 80.35 %. Cryo-TEM confirmed the presence of well-ordered cubic nanostructures, and the dispersion was homogeneous, smooth, milky white and physically stable under storage conditions.In conclusion, the study successfully developed a stable, effective and patient-friendly acetazolamide in-situ cubogel.
"synopsis" may belong to another edition of this title.
Seller: PBShop.store UK, Fairford, GLOS, United Kingdom
PAP. Condition: New. New Book. Delivered from our UK warehouse in 4 to 14 business days. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000. Seller Inventory # L0-9786630466096
Quantity: Over 20 available
Seller: PBShop.store US, Wood Dale, IL, U.S.A.
PAP. Condition: New. New Book. Shipped from UK. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000. Seller Inventory # L0-9786630466096
Seller: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Germany
Taschenbuch. Condition: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware 96 pp. Englisch. Seller Inventory # 9786630466096
Seller: Grand Eagle Retail, Bensenville, IL, U.S.A.
Paperback. Condition: new. Paperback. Glaucoma is a chronic eye disorder characterized by elevated intraocular pressure, which can lead to optic nerve damage and irreversible vision loss if untreated. Acetazolamide, a carbonic anhydrase inhibitor, effectively reduces aqueous humor production, but conventional ocular formulations are limited by poor bioavailability, rapid precorneal clearance, and the need for frequent dosing. To address these challenges, an acetazolamide-loaded in-situ cubogel was developed to provide sustained, targeted, and patient-friendly ocular delivery.Cubosomes were prepared using the top-down technique and optimized through a Box-Behnken Design. The optimized cubosome formulation contained 6.2% w/v Glyceryl monooleate, 0.35% w/v Pluronic F127 and 6.8 minutes sonication time, resulting in particle size of 256.7 nm, PDI of 0.473, zetapotential of 7.53 mV and entrapment efficiency of 80.35 %. Cryo-TEM confirmed the presence of well-ordered cubic nanostructures, and the dispersion was homogeneous, smooth, milky white and physically stable under storage conditions.In conclusion, the study successfully developed a stable, effective and patient-friendly acetazolamide in-situ cubogel. This item is printed on demand. Shipping may be from multiple locations in the US or from the UK, depending on stock availability. Seller Inventory # 9786630466096
Seller: AHA-BUCH GmbH, Einbeck, Germany
Taschenbuch. Condition: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering. Seller Inventory # 9786630466096
Seller: CitiRetail, Stevenage, United Kingdom
Paperback. Condition: new. Paperback. Glaucoma is a chronic eye disorder characterized by elevated intraocular pressure, which can lead to optic nerve damage and irreversible vision loss if untreated. Acetazolamide, a carbonic anhydrase inhibitor, effectively reduces aqueous humor production, but conventional ocular formulations are limited by poor bioavailability, rapid precorneal clearance, and the need for frequent dosing. To address these challenges, an acetazolamide-loaded in-situ cubogel was developed to provide sustained, targeted, and patient-friendly ocular delivery.Cubosomes were prepared using the top-down technique and optimized through a Box-Behnken Design. The optimized cubosome formulation contained 6.2% w/v Glyceryl monooleate, 0.35% w/v Pluronic F127 and 6.8 minutes sonication time, resulting in particle size of 256.7 nm, PDI of 0.473, zetapotential of 7.53 mV and entrapment efficiency of 80.35 %. Cryo-TEM confirmed the presence of well-ordered cubic nanostructures, and the dispersion was homogeneous, smooth, milky white and physically stable under storage conditions.In conclusion, the study successfully developed a stable, effective and patient-friendly acetazolamide in-situ cubogel. This item is printed on demand. Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability. Seller Inventory # 9786630466096
Quantity: 1 available
Seller: preigu, Osnabrück, Germany
Taschenbuch. Condition: Neu. Formulation and Characterization of Acetazolamide In Situ Cubogel | In Situ Cubogel Formulation for Glaucoma Management | Farhad F Mehta (u. a.) | Taschenbuch | Englisch | 2026 | LAP LAMBERT Academic Publishing | EAN 9786630466096 | Verantwortliche Person für die EU: preigu GmbH & Co. KG, Lengericher Landstr. 19, 49078 Osnabrück, mail[at]preigu[dot]de | Anbieter: preigu Print on Demand. Seller Inventory # 138079288
Seller: buchversandmimpf2000, Emtmannsberg, BAYE, Germany
Taschenbuch. Condition: Neu. This item is printed on demand - Print on Demand Titel. Neuware 96 pp. Englisch. Seller Inventory # 9786630466096
Seller: Home-set, Mannheim, Germany
Softcover/Taschenbuch. Condition: Neu. Neuware, Lieferung aus Deutschland. Sprache: Englisch Gewicht in Gramm: 161. Seller Inventory # IB-1615700